SCWorx Corp. 8-K
Research Summary
AI-generated summary
SCWorx Corp Receives Nasdaq Notice Over Market Value Deficiency
What Happened SCWorx Corp (WORX) filed an 8-K on July 29, 2026 reporting that by letter dated July 24, 2026 Nasdaq notified the company that its Market Value of Publicly Held Shares (MVPHS) fell below the required $1,000,000 during the 30-business-day period from June 10, 2026 to July 23, 2026. Nasdaq has provided a 180-calendar-day compliance period through January 20, 2027 for the company to regain the minimum MVPHS requirement.
Key Details
- Nasdaq cited noncompliance with Listing Rule 5550(a)(5) (minimum MVPHS of $1,000,000).
- Deficiency period referenced: June 10, 2026 — July 23, 2026; Nasdaq letter dated July 24, 2026.
- Compliance cure window: 180 days ending January 20, 2027; Nasdaq will confirm compliance if MVPHS ≥ $1,000,000 for at least 10 consecutive business days (Nasdaq may require up to ~20 days).
- If compliance is not regained, Nasdaq may move to delist; the company can appeal to a hearings panel. The board has not yet determined what steps it will take.
Why It Matters This notice signals a risk to the company’s continued Nasdaq listing if SCWorx cannot raise its market value of publicly held shares above $1 million within the allotted cure period. For investors, that risk can affect liquidity, access to institutional investors, and share price volatility. The company is evaluating options to regain and sustain compliance, but there is no assurance the efforts will succeed.
Loading document...